A Unique E4/E5 Insertion Mutation of ABL Kinase in a BCR ABL (+) Patient

被引：0
|
作者：
Leonard, G. [1 ]
Rempfer, C. [1 ]
Pertain, J. [1 ]
Press, R. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
  • [31] Coordinated Expression of HPV-6 Genes with Predominant E4 and E5 Expression in Laryngeal Papilloma
    Ikegami, Taro
    Hirakawa, Hitoshi
    Tsukahara, Narutoshi
    Murakami, Akikazu
    Kise, Norimoto
    Kiyuna, Asanori
    Kosugi, Takayoshi
    Agena, Shinya
    Kinjyo, Hidetoshi
    Hasegawa, Narumi
    Touyama, Masatomo
    Kondo, Shunsuke
    Maeda, Hiroyuki
    Suzuki, Mikio
    Ganaha, Akira
    MICROORGANISMS, 2021, 9 (03) : 1 - 18
  • [32] The patient's BCR-ABL1 Kinase Domain Mutation History Is Important for Decisions Regarding Tyrosine Kinase Inhibitor Therapy
    Parker, Wendy T.
    Yeoman, Alexandra L.
    Jamison, Bronte A.
    Yeung, David T.
    Scott, Hamish S.
    Hughes, Timothy P.
    Branford, Susan
    BLOOD, 2012, 120 (21)
  • [33] The e19a2 bcr/abl breakpoint in acute lymphoblastic leukaemia
    Rotoli, B
    Pane, F
    Salvatore, F
    Saglio, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (02) : 493 - 496
  • [34] Combined targeting of GPX4 and BCR-ABL tyrosine kinase selectively compromises BCR-ABL plus leukemia stem cells
    Zeng, Chengwu
    Nie, Dingrui
    Wang, Xianfeng
    Zhong, Shuxin
    Zeng, Xiangbo
    Liu, Xin
    Qiu, Kangjie
    Peng, Xueting
    Zhang, Wenyi
    Chen, Shengting
    Zha, Xianfeng
    Chen, Cunte
    Chen, Zhenhua
    Wang, Weizhang
    Li, Yangqiu
    MOLECULAR CANCER, 2024, 23 (01)
  • [35] An intron-derived insertion/truncation mutation in the BCR-ABL kinase domain in chronic myeloid leukemia patients undergoing kinase inhibitor therapy
    Laudadio, Jennifer
    Deininger, Michael W. N.
    Mauro, Michael J.
    Druker, Brian J.
    Press, Richard D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (02): : 177 - 180
  • [36] Bcr-abl-tyrosine-kinase-inhibitorsVarious toxicities: 4 case reports
    Reactions Weekly, 2024, 2036 (1) : 88 - 88
  • [37] Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
    McCarron, Sarah L. y
    Maher, Karena
    Kelly, Johanna
    Ryan, Mary F.
    Langabeer, Stephen E.
    CASE REPORTS IN HEMATOLOGY, 2013, 2013
  • [38] Second case of CML with aberrant BCR-ABL fusion transcript (e8/a2) with insertion of an inverted ABL intron 1b sequence
    Sugimoto, T
    Ijima, K
    Hisatomi, H
    Murayama, T
    Mizuno, I
    Hato, A
    Imoto, S
    Nishimura, R
    Koizumi, T
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (02) : 164 - 166
  • [39] ImatinibDrug resistance due to 35 nucleotides BCR-ABL1 insertion mutation: case report
    Reactions Weekly, 2015, 1555 (1) : 104 - 104
  • [40] Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line
    Ricci, C
    Scappini, B
    Divoky, V
    Gatto, S
    Onida, F
    Verstovsek, S
    Kantarjian, HM
    Beran, M
    CANCER RESEARCH, 2002, 62 (21) : 5995 - 5998
12345